JP5323680B2 - 結腸直腸細胞増殖性疾患を検出するための方法および核酸 - Google Patents

結腸直腸細胞増殖性疾患を検出するための方法および核酸 Download PDF

Info

Publication number
JP5323680B2
JP5323680B2 JP2009505769A JP2009505769A JP5323680B2 JP 5323680 B2 JP5323680 B2 JP 5323680B2 JP 2009505769 A JP2009505769 A JP 2009505769A JP 2009505769 A JP2009505769 A JP 2009505769A JP 5323680 B2 JP5323680 B2 JP 5323680B2
Authority
JP
Japan
Prior art keywords
sequence
seq
methylation
nucleic acid
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2009505769A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009533066A (ja
JP2009533066A5 (fr
Inventor
ロフトン‐デイ，キャサリン
エベルト，マティアス
Original Assignee
エピゲノミクス アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2006/014131 external-priority patent/WO2006113466A2/fr
Application filed by エピゲノミクス アーゲー filed Critical エピゲノミクス アーゲー
Publication of JP2009533066A publication Critical patent/JP2009533066A/ja
Publication of JP2009533066A5 publication Critical patent/JP2009533066A5/ja
Application granted granted Critical
Publication of JP5323680B2 publication Critical patent/JP5323680B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
JP2009505769A 2006-04-17 2007-04-17 結腸直腸細胞増殖性疾患を検出するための方法および核酸 Active JP5323680B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
USPCT/US2006/014131 2006-04-17
PCT/US2006/014131 WO2006113466A2 (fr) 2005-04-15 2006-04-17 Methodes et acides nucleiques utilises dans des analyses de troubles proliferatifs cellulaires
EP06090119 2006-06-27
EP06090119.6 2006-06-27
PCT/EP2007/003380 WO2007118704A2 (fr) 2006-04-17 2007-04-17 Procédés et acides nucléiques pour détecter des troubles de prolifération de cellules colorectales

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013123304A Division JP5846693B2 (ja) 2006-04-17 2013-06-12 結腸直腸細胞増殖性疾患を検出するための方法および核酸

Publications (3)

Publication Number Publication Date
JP2009533066A JP2009533066A (ja) 2009-09-17
JP2009533066A5 JP2009533066A5 (fr) 2011-04-28
JP5323680B2 true JP5323680B2 (ja) 2013-10-23

Family

ID=40030469

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009505769A Active JP5323680B2 (ja) 2006-04-17 2007-04-17 結腸直腸細胞増殖性疾患を検出するための方法および核酸
JP2013123304A Expired - Fee Related JP5846693B2 (ja) 2006-04-17 2013-06-12 結腸直腸細胞増殖性疾患を検出するための方法および核酸

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013123304A Expired - Fee Related JP5846693B2 (ja) 2006-04-17 2013-06-12 結腸直腸細胞増殖性疾患を検出するための方法および核酸

Country Status (7)

Country Link
US (1) US20220260570A1 (fr)
EP (3) EP2013360A2 (fr)
JP (2) JP5323680B2 (fr)
AU (1) AU2007237444B2 (fr)
CA (1) CA2649777C (fr)
ES (1) ES2587068T3 (fr)
WO (1) WO2007118704A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2533767T3 (es) 2005-04-15 2015-04-15 Epigenomics Ag Métodos para el análisis de trastornos proliferativos celulares
WO2008122447A2 (fr) * 2007-04-10 2008-10-16 Epigenomics Ag Dosage de méthylation d'adn permettant de réaliser le diagnostic ou le pronostic d'états pathologiques
ES2715226T3 (es) * 2010-09-13 2019-06-03 Clinical Genomics Pty Ltd Marcadores epigenéticos de cánceres colorrectales y métodos de diagnóstico que los usan
FR2967165B1 (fr) * 2010-11-04 2014-10-10 Assist Publ Hopitaux De Paris Methode de depistage du cancer colorectal
CA2840149C (fr) 2011-07-08 2021-10-26 Epigenomics Ag Methodes et acides nucleiques permettant d'etablir le pronostic d'un sujet atteint de cancer
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
US10706957B2 (en) 2012-09-20 2020-07-07 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
CN104046680B (zh) * 2013-03-11 2016-04-06 苏州承美生物科技有限公司 甲基化dna检测方法
KR102587812B1 (ko) 2014-06-04 2023-10-10 퀘스트 다이어그노스틱스 인베스트먼츠 인코포레이티드 결장직장암에 대한 메틸화된 마커
EP3521448A4 (fr) * 2016-09-29 2020-07-29 Hanumat Co., Ltd. Procédé permettant de déterminer le risque d'apparition du cancer sporadique du côlon
WO2018087129A1 (fr) * 2016-11-08 2018-05-17 Region Nordjylland, Aalborg University Hospital Marqueurs de méthylation du cancer colorectal
EP3660172A1 (fr) * 2018-11-28 2020-06-03 Bioscreening and Diagnostics LLC Procédés de diagnostic de lésions cérébrales traumatiques
CN111826441A (zh) * 2019-04-23 2020-10-27 博尔诚（北京）科技有限公司 用于体外检测消化道五癌的体系，在该体系中使用的组合物，以及包含该组合物的试剂盒
CN112195243A (zh) * 2020-09-22 2021-01-08 北京华大吉比爱生物技术有限公司 一种检测多基因甲基化的试剂盒及其应用

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585481A (en) 1987-09-21 1996-12-17 Gen-Probe Incorporated Linking reagents for nucleotide probes
US5457183A (en) 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
US5667976A (en) * 1990-05-11 1997-09-16 Becton Dickinson And Company Solid supports for nucleic acid hybridization assays
US5245022A (en) 1990-08-03 1993-09-14 Sterling Drug, Inc. Exonuclease resistant terminally substituted oligonucleotides
US6582908B2 (en) * 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
DE69231903T2 (de) * 1991-01-04 2001-10-31 Univ St Louis Mit isoliertem empfindlichem x-syndrom verbundene dns-sequenzen
US5565552A (en) 1992-01-21 1996-10-15 Pharmacyclics, Inc. Method of expanded porphyrin-oligonucleotide conjugate synthesis
US5364787A (en) * 1992-03-23 1994-11-15 Idaho Research Foundation Genes and enzymes involved in the microbial degradation of pentachlorophenol
US5574142A (en) 1992-12-15 1996-11-12 Microprobe Corporation Peptide linkers for improved oligonucleotide delivery
SE501439C2 (sv) 1993-06-22 1995-02-13 Pharmacia Lkb Biotech Sätt och anordning för analys av polynukleotidsekvenser
JPH09506253A (ja) 1993-11-30 1997-06-24 マクギル・ユニヴァーシティ Ｄｎａメチルトランスフェラーゼの阻害
US5597696A (en) 1994-07-18 1997-01-28 Becton Dickinson And Company Covalent cyanine dye oligonucleotide conjugates
US5514758A (en) 1994-09-30 1996-05-07 The Goodyear Tire & Rubber Company Process for making latex for high performance masking tape
US6017704A (en) 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US5786146A (en) 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US6251594B1 (en) 1997-06-09 2001-06-26 Usc/Norris Comprehensive Cancer Ctr. Cancer diagnostic method based upon DNA methylation differences
DE19754482A1 (de) 1997-11-27 1999-07-01 Epigenomics Gmbh Verfahren zur Herstellung komplexer DNA-Methylierungs-Fingerabdrücke
US7700324B1 (en) 1998-11-03 2010-04-20 The Johns Hopkins University School Of Medicine Methylated CpG island amplification (MCA)
US5958773A (en) 1998-12-17 1999-09-28 Isis Pharmaceuticals Inc. Antisense modulation of AKT-1 expression
US6331393B1 (en) 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
US6783933B1 (en) * 1999-09-15 2004-08-31 The Johns Hopkins University School Of Medicine CACNA1G polynucleotide, polypeptide and methods of use therefor
WO2005000087A2 (fr) * 2003-06-03 2005-01-06 Chiron Corporation Produits genetiques exprimes de facon differentielle dans des cellules cancereuses du colon et leurs methodes d'utilisation ii
EP1373564A2 (fr) * 2000-09-01 2004-01-02 Epigenomics AG Diagnostic de maladies declarees ou de la predisposition a certaines maladies
US7473767B2 (en) 2001-07-03 2009-01-06 The Institute For Systems Biology Methods for detection and quantification of analytes in complex mixtures
WO2003042661A2 (fr) * 2001-11-13 2003-05-22 Protein Design Labs, Inc. Methodes de diagnostic du cancer, compositions et methodes de criblage des modulateurs du cancer
EP1554407B1 (fr) 2002-10-01 2009-07-29 Epigenomics AG Procede en vue du traitement de troubles de la proliferation de celllules mammaires
WO2004074441A2 (fr) * 2003-02-19 2004-09-02 Government Of The United States Of America Represented By The Secretary Department Of Health And Human Services Amplification ou surexpression de la fusion du type septine mll (msf), septine9 et procedes connexes
CA2531451A1 (fr) * 2003-06-23 2005-01-06 Epigenomics Ag Methodes et acides nucleiques pour l'analyse de troubles de la proliferation de cellules colorectales
ATE494390T1 (de) * 2003-06-23 2011-01-15 Epigenomics Ag Verfahren und nukleinsäuren zur analyse von störungen der proliferation von kolonzellen
WO2005123945A2 (fr) * 2004-06-21 2005-12-29 Epigenomics Ag Marqueurs epigenetiques destines au traitement du cancer du sein
EP2302073A1 (fr) * 2004-07-18 2011-03-30 Epigenomics AG Procédés épigénétiques et acides nucléiques pour la détection de troubles cellulaires proliférables du sein
ES2533767T3 (es) * 2005-04-15 2015-04-15 Epigenomics Ag Métodos para el análisis de trastornos proliferativos celulares

Also Published As

Publication number Publication date
WO2007118704A3 (fr) 2008-04-24
EP2479283A1 (fr) 2012-07-25
EP2013360A2 (fr) 2009-01-14
EP2484778A2 (fr) 2012-08-08
JP5846693B2 (ja) 2016-01-20
JP2009533066A (ja) 2009-09-17
CA2649777A1 (fr) 2007-10-25
AU2007237444A1 (en) 2007-10-25
WO2007118704A2 (fr) 2007-10-25
EP2484778A3 (fr) 2012-10-10
EP2479283B1 (fr) 2016-06-22
US20220260570A1 (en) 2022-08-18
JP2013230153A (ja) 2013-11-14
CA2649777C (fr) 2018-08-14
AU2007237444B2 (en) 2013-05-23
ES2587068T3 (es) 2016-10-20

Similar Documents

Publication Publication Date Title
US11186879B2 (en) Methods and nucleic acids for analyses of cellular proliferative disorders
JP5846693B2 (ja) 結腸直腸細胞増殖性疾患を検出するための方法および核酸
JP5818374B2 (ja) 細胞増殖性障害の検出のための方法及び核酸
JP6017497B2 (ja) 前立腺細胞増殖性障害の発症に関連する遺伝子の発現を解析する方法及び核酸
US20090317810A1 (en) Methods and nucleic acids for the detection of colorectal cell proliferative disorders
JP4955385B2 (ja) 結腸直腸細胞増殖障害の分析のための方法及び核酸
EP2044221A2 (fr) Procédés et acides nucléiques destinés aux analyses de troubles associés à une prolifération cellulaire
US20100184027A1 (en) Methods and nucleic acids for analyses of cellular proliferative disorders
WO2007115213A2 (fr) Méthodes et acides nucléiques pour des analyses de troubles prolifératifs cellulaires
US20110171637A1 (en) Methods and nucleic acids for analyses of cellular proliferative disorders

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100319

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100319

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110302

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120629

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120914

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120924

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121015

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121022

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121115

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121122

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121226

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130212

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130612

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20130619

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130708

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130717

R150 Certificate of patent or registration of utility model

Ref document number: 5323680

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250